glp-1 made from Companies seek a second obesity treatment revolution—in pill form | Science GLP-1 Drugs and Eating Disorders:

2015;10:e0126804

It enhances hepatocyte proliferation, migration, invasion, cytoskeletal remodeling, and lipid dysregulation, further promoting liver injury and carcinogenesis (4548)

doi: 10.1016/j.physbeh.2016.03.016

Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the Cyclic adenosine monophosphate/nuclear factor-B pathway in vitro

All infections were performed using a standardized inoculum of 1 10 7 colony-forming units (CFU) suspended in phosphate-buffered saline (PBS) and administered via the intranasal route using 50 l/nostril

(3) oral ALA at 600 mg/day is equally effective as IV treatment